Aims to redefine orthopaedic recovery and rehabilitation in India
Bengaluru-based Lumov, an innovator in orthopaedic recovery and rehabilitation products space, has raised a Seed Round of Rs 10 crore/ $1.2 million led by Incubate Fund Asia, with participation from QRG Investments and Holdings (Havells Family Office), IIMA Ventures, SIDBI, and several other noted angel investors, including Ashish Gupta (Helion Advisors), Saket Narang (Steinberg India), Abhishek Goyal (Tracxn), Arjun Vaidya, Indian Silicon Valley, Mapaex Family Office and others also participated in the round. The newly raised capital will fuel Lumov’s growth, expansion, and deepen its product development pipeline.
Lumov designs and manufactures advanced orthopedic products and orthoses that support post-surgical recovery, rehabilitation, and lifestyle-driven pain management. Lumov’s comprehensive range of products is engineered for clinical effectiveness, patient comfort, and India-specific anatomy and weather conditions, ensuring better compliance and improved recovery outcomes. The company develops its product with eminent orthopedic specialists at hospital chains such as Manipal, Apollo, Sakra, and AIG.
The company will use the fresh capital to drive growth, deepen collaboration with top orthopedic surgeons across India, and accelerate the development of the next generation of products. The fund will also support geographic expansion into Delhi NCR, Hyderabad, and Mumbai, scaling its sales operations and strengthening its manufacturing capabilities for post-surgical and rehab-focused bracing products. Lumov currently has a core team of 15 members, which will grow significantly as part of this expansion effort.
Co-Founders, Saumaric Dangwal and Ankit Gupta, shared, “India is in the midst of an orthopaedic health crisis. While advances in diagnostics and care delivery are improving outcomes, we are building the physical product layer, premium, high-quality orthotics, rehabilitation aids, and pain-management solutions designed to accelerate recovery and help people live pain-free, active lives.”
“The musculoskeletal (MSK) care category, particularly in post-surgical recovery, rehabilitation, and lifestyle-driven pain relief, is poised for significant innovation. Lumov’s surgeon-led approach, Saumaric and Ankit’s profound market understanding, and integration of modern design principles instill high confidence that they can emerge as a category-defining company in MSK care,” said Rajeev Ranka, Partner at Incubate Fund Asia.
Ramesh Sharma, President of QRG Investments & Holdings, “What impressed us about Lumov is not just the product portfolio, but the long-term vision to build an integrated MSK products platform. Saumaric and Ankit bring clarity of thought, speed of execution, and strong clinical partnerships that position Lumov to build a category-creating company in musculoskeletal health.”
